Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Alosaimy

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of Microbiological Methods|November 23, 2018
Exploring anti-MRSA activity of chitosan-coated liposomal dicloxacillinAws Alshamsan, Fadilah Sfouq Aleanizy, Mohamed Badran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2020
Vancomycin Area Under the Curve to Predict Timely Clinical Response in the Treatment of Methicillin-resistant Staphylococcus aureus Complicated Skin and Soft Tissue InfectionsSara Alosaimy, Kyle P Murray, Evan J Zasowski, et al.
Bone Marrow Transplantation|April 2, 2020
Defibrotide formulations contain (1→3)-β-D-glucan that could influence clinical diagnostic testingSara Alosaimy, Mary Nauffal, Robert Soiffer, et al.
Infectious Diseases and Therapy|May 14, 2022
Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative PathogensTaylor Morrisette, Sara Alosaimy, Abdalhamid M Lagnf, et al.
Infectious Diseases and Therapy|September 1, 2022
Impact of Ceftolozane-Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract InfectionsDana J Holger, Nicholas S Rebold, Sara Alosaimy, et al.
Infectious Diseases and Therapy|April 6, 2020
Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort AnalysisSara Alosaimy, Noor L Sabagha, Abdalhamid M Lagnf, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 19, 2021
Impact of COVID-19 pandemic on training of pharmacy residents and fellows: Results from a national survey of postgraduate pharmacy traineesW Justin Moore, Andrew Webb, Taylor Morrisette, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2019
Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort StudySarah C J Jorgensen, Evan J Zasowski, Trang D Trinh, et al.
Open Forum Infectious Diseases|May 16, 2020
Early Experience With Eravacycline for Complicated InfectionsSara Alosaimy, Kyle C Molina, Kimberly C Claeys, et al.
Microbiology Spectrum|January 9, 2023
Risk Factors for Carbapenem-Resistant <i>Enterobacterales</i> Clinical Treatment FailureNicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of Microbiological Methods|November 23, 2018
Exploring anti-MRSA activity of chitosan-coated liposomal dicloxacillinAws Alshamsan, Fadilah Sfouq Aleanizy, Mohamed Badran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2020
Vancomycin Area Under the Curve to Predict Timely Clinical Response in the Treatment of Methicillin-resistant Staphylococcus aureus Complicated Skin and Soft Tissue InfectionsSara Alosaimy, Kyle P Murray, Evan J Zasowski, et al.
Bone Marrow Transplantation|April 2, 2020
Defibrotide formulations contain (1→3)-β-D-glucan that could influence clinical diagnostic testingSara Alosaimy, Mary Nauffal, Robert Soiffer, et al.
Infectious Diseases and Therapy|May 14, 2022
Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative PathogensTaylor Morrisette, Sara Alosaimy, Abdalhamid M Lagnf, et al.
Infectious Diseases and Therapy|September 1, 2022
Impact of Ceftolozane-Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract InfectionsDana J Holger, Nicholas S Rebold, Sara Alosaimy, et al.
Infectious Diseases and Therapy|April 6, 2020
Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort AnalysisSara Alosaimy, Noor L Sabagha, Abdalhamid M Lagnf, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 19, 2021
Impact of COVID-19 pandemic on training of pharmacy residents and fellows: Results from a national survey of postgraduate pharmacy traineesW Justin Moore, Andrew Webb, Taylor Morrisette, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2019
Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort StudySarah C J Jorgensen, Evan J Zasowski, Trang D Trinh, et al.
Open Forum Infectious Diseases|May 16, 2020
Early Experience With Eravacycline for Complicated InfectionsSara Alosaimy, Kyle C Molina, Kimberly C Claeys, et al.
Microbiology Spectrum|January 9, 2023
Risk Factors for Carbapenem-Resistant <i>Enterobacterales</i> Clinical Treatment FailureNicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, et al.
Pageof 4